 |
 |
 |
|
 |
|
FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page  |
||||
Transfer of Therapeutic Products |
| Product Name | Proprietary Name | Applicant Name |
| Abciximab | ReoPro | Centocor B.V. |
| Adalimumab | Humira | Abbott Laboratories |
| Agalsidase beta | Fabrazyme | Genzyme Corp |
| Aldesleukin | Proleukin | Chiron Corp |
| Alefacept | Amevive | Biogen, Inc |
| Alemtuzumab | Campath | ILEX Pharmaceuticals L.P. |
| Alteplase | Activase | Genentech, Inc |
| Anakinra | Kineret | Amgen, Inc |
| Anistreplase | Eminase | Wulfing Pharma GmbH |
| Arcitumomab | CEA-Scan | Immunomedics, Inc |
| Asparaginase | Elspar | Merck & Co., Inc |
| Basiliximab | Simulect | Novartis Pharmaceuticals Corp |
| Becaplermin | Regranex | OMJ Pharmaceuticals, Inc |
| Becaplermin Concentrate | Chiron Corp | |
| Botulinum Toxin Type A | BOTOX BOTOX COSMETIC |
Allergan, Inc |
| Botulinum Toxin Type B | MYOBLOC | Elan Pharmaceuticals |
| Capromab Pendetide | ProstaScint | Cytogen Corp |
| Collagenase | Santyl | Advance Biofactures Corp |
| Daclizumab | Zenapax | Hoffmann-La Roche Inc |
| Darbepoetin alfa | Aranesp | Amgen, Inc |
| Denileukin diftitox | Ontak | Seragen, Inc |
| Dornase alfa | Pulmozyme | Genentech, Inc |
| Drotrecogin alfa (Activated) | Xigris | Eli Lilly & Co |
| Epoetin alfa | Epogen | Amgen, Inc |
| Epoetin alfa | Eprex | Ortho Biologics LLC |
| Etanercept | Enbrel | Immunex Corp |
| Filgrastim | Neupogen | Amgen, Inc |
| Ibritumomab tiuxetan | Zevalin | IDEC Pharmaceuticals Corp |
| Indium In-111 Chloride Sterile Solution | Indium In-111 Chloride Sterile Solution | Mallinckrodt Medical, Inc |
| Indium In-111 Chloride Sterile Solution | Indiclor | Medi-Physics, Inc |
| Infliximab | Remicade | Centocor, Inc |
| Interferon alfa-2a | Roferon A | Hoffmann-La Roche Inc |
| Interferon alfa-2b | Intron A | Schering Corp |
| Interferon alfacon-1 | Infergen | InterMune, Inc |
| Interferon alfa-n3 (Human Leukocyte Derived) | Alferon N Injection | Interferon Sciences, Inc |
| Interferon beta-1a | Avonex | Biogen, Inc |
| Interferon beta-1a | Rebif | Serono, Inc |
| Interferon beta-1b | Betaseron | Chiron Corp |
| Interferon gamma-1b | Actimmune | InterMune, Inc |
| Laronidase | Aldurazyme | Biomarin Pharmaceutical Inc |
| Muromonab-CD3 | Orthoclone OKT3 | Ortho Biotech Products, LP |
| Nofetumomab | Verluma | Boehringer Ingelheim Pharma KG |
| Omalizumab | Xolair | Genentech, Inc |
| Oprelvekin | Neumega | Genetics Institute, Inc |
| Palivizumab | Synagis | MedImmune, Inc |
| Pegaspargase | Oncaspar | Enzon, Inc |
| Pegfilgrastim | Neulasta | Amgen, Inc |
| Peginterferon alfa-2a | Pegasys | Hoffman-La Roche Inc |
| Peginterferon alfa-2b | PEG-Intron | Schering Corp |
| Rasburicase | Elitek | Sanofi-Synthelabo, Inc |
| Reteplase | Retavase | Centocor, Inc |
| Rituximab | Rituxan | Genentech, Inc |
| Rituximab Formulated Bulk (For Further Manufacturing Use) | IDEC Pharmaceuticals Corp | |
| Sargramostim | Leukine | Berlex Laboratories, Inc |
| Satumomab Concentrate (For Further Manufacturing Use) | LONZA Biologics plc | |
| Satumomab Pendetide | OncoScint CR/OV | Cytogen Corp |
| Streptokinase | Streptase | Aventis Behring GmbH |
| Tenecteplase | TNKase | Genentech, Inc |
| Tositumomab and Iodine I 131 Tositumomab | Bexxar | Corixa Corp |
| Trastuzumab | Herceptin | Genentech, Inc |
| Urokinase | Abbokinase | Abbott Laboratories - Pharmaceutical Products Division |
|